Catherine Coste - Dec 13, 2023 Form 4 Insider Report for BIOMERICA INC (BMRA)

Role
Director
Signature
/s/ Catherine Coste
Stock symbol
BMRA
Transactions as of
Dec 13, 2023
Transactions value $
$0
Form type
4
Date filed
12/14/2023, 05:10 PM
Previous filing
Dec 11, 2023
Next filing
Dec 17, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMRA Common stock 43.8K Dec 13, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRA Non-qualified stock option Award +75K 75K Dec 13, 2023 Common Stock 75K $1.01 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted to Ms. Coste as part of her Fiscal 2024 Board compensation package.
F2 Not Applicable